Cargando…

Prognostic Value of Triglyceride to High-Density Lipoprotein Cholesterol Ratio (TG/HDL-C) in IgA Nephropathy Patients

BACKGROUND: The triglycerides to high-density lipoprotein cholesterol (TG/HDL-C) ratio is an easy-to-use atherogenic and prognostic marker which has attracted increasing attention these days. However, whether TG/HDL-C correlate with outcomes in IgA nephropathy (IgAN) patients remains unknown. To cla...

Descripción completa

Detalles Bibliográficos
Autores principales: Pei, Gaiqin, Qin, Aiya, Dong, Lingqiu, Wang, Siqing, Liu, Xiang, Yang, Dandan, Tan, Jiaxing, Zhou, Xiaoyuan, Tang, Yi, Qin, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251124/
https://www.ncbi.nlm.nih.gov/pubmed/35795149
http://dx.doi.org/10.3389/fendo.2022.877794
_version_ 1784739969701511168
author Pei, Gaiqin
Qin, Aiya
Dong, Lingqiu
Wang, Siqing
Liu, Xiang
Yang, Dandan
Tan, Jiaxing
Zhou, Xiaoyuan
Tang, Yi
Qin, Wei
author_facet Pei, Gaiqin
Qin, Aiya
Dong, Lingqiu
Wang, Siqing
Liu, Xiang
Yang, Dandan
Tan, Jiaxing
Zhou, Xiaoyuan
Tang, Yi
Qin, Wei
author_sort Pei, Gaiqin
collection PubMed
description BACKGROUND: The triglycerides to high-density lipoprotein cholesterol (TG/HDL-C) ratio is an easy-to-use atherogenic and prognostic marker which has attracted increasing attention these days. However, whether TG/HDL-C correlate with outcomes in IgA nephropathy (IgAN) patients remains unknown. To clarify these issues, we conducted this study. METHODS: A total of 1146 patients from West China Hospital of Sichuan University were retrospectively analysed between 2008 and 2018.The demographic, clinical and pathological data of all patients at the time of biopsy were collected. Then, patients were divided into the high TG/HDL group (TG/HDL ≥ 1.495, N=382) and the low TG/HDL group (TG/HDL-C < 1.495, N=764) based on the optimal cut-off value of the TG/HDL-C using receive operating curve. Cox proportional hazard models and Kaplan–Meier curves were used to evaluate the renal outcomes of IgAN. RESULTS: The median age of the patients was 33 (26-42) years, and 44.5% were men. By correlation analysis, we found that the TG/HDL-C ratio was negatively correlated with the eGFR (r = 0.250, P < 0.001) but positively correlated with proteinuria (r = 0.230, P< 0.001), BMI (r=0.380, P<0.001) and serum uric (r =0.308, P< 0.001). Patients with a higher TG/HDL-C ratio tended to have hypertension [odds ratio (OR), 1.987; 95% CI, 1.527-2.587; P<0.001] and more severe pathologic lesions with tubular atrophy/interstitial fibrosis (OR, 1.610; 95% CI, 1.203-2.154; P=0.001). During a median follow-up period of 54.1 (35.6-73.2) months, a high TG/HDL ratio was strongly associated with worse renal survival in IgAN patients (log-rank: P <0.001). Multivariate Cox analysis demonstrated that a high TG/HDL-C ratio (HR 1.775, 95% CI 1.056-2.798; P=0.029) was an independent predictive marker to ESRD. CONCLUSION: In this study, we addressed the importance of TG/HDL-C ratio as a predictive marker for IgAN progression.
format Online
Article
Text
id pubmed-9251124
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92511242022-07-05 Prognostic Value of Triglyceride to High-Density Lipoprotein Cholesterol Ratio (TG/HDL-C) in IgA Nephropathy Patients Pei, Gaiqin Qin, Aiya Dong, Lingqiu Wang, Siqing Liu, Xiang Yang, Dandan Tan, Jiaxing Zhou, Xiaoyuan Tang, Yi Qin, Wei Front Endocrinol (Lausanne) Endocrinology BACKGROUND: The triglycerides to high-density lipoprotein cholesterol (TG/HDL-C) ratio is an easy-to-use atherogenic and prognostic marker which has attracted increasing attention these days. However, whether TG/HDL-C correlate with outcomes in IgA nephropathy (IgAN) patients remains unknown. To clarify these issues, we conducted this study. METHODS: A total of 1146 patients from West China Hospital of Sichuan University were retrospectively analysed between 2008 and 2018.The demographic, clinical and pathological data of all patients at the time of biopsy were collected. Then, patients were divided into the high TG/HDL group (TG/HDL ≥ 1.495, N=382) and the low TG/HDL group (TG/HDL-C < 1.495, N=764) based on the optimal cut-off value of the TG/HDL-C using receive operating curve. Cox proportional hazard models and Kaplan–Meier curves were used to evaluate the renal outcomes of IgAN. RESULTS: The median age of the patients was 33 (26-42) years, and 44.5% were men. By correlation analysis, we found that the TG/HDL-C ratio was negatively correlated with the eGFR (r = 0.250, P < 0.001) but positively correlated with proteinuria (r = 0.230, P< 0.001), BMI (r=0.380, P<0.001) and serum uric (r =0.308, P< 0.001). Patients with a higher TG/HDL-C ratio tended to have hypertension [odds ratio (OR), 1.987; 95% CI, 1.527-2.587; P<0.001] and more severe pathologic lesions with tubular atrophy/interstitial fibrosis (OR, 1.610; 95% CI, 1.203-2.154; P=0.001). During a median follow-up period of 54.1 (35.6-73.2) months, a high TG/HDL ratio was strongly associated with worse renal survival in IgAN patients (log-rank: P <0.001). Multivariate Cox analysis demonstrated that a high TG/HDL-C ratio (HR 1.775, 95% CI 1.056-2.798; P=0.029) was an independent predictive marker to ESRD. CONCLUSION: In this study, we addressed the importance of TG/HDL-C ratio as a predictive marker for IgAN progression. Frontiers Media S.A. 2022-06-20 /pmc/articles/PMC9251124/ /pubmed/35795149 http://dx.doi.org/10.3389/fendo.2022.877794 Text en Copyright © 2022 Pei, Qin, Dong, Wang, Liu, Yang, Tan, Zhou, Tang and Qin https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Pei, Gaiqin
Qin, Aiya
Dong, Lingqiu
Wang, Siqing
Liu, Xiang
Yang, Dandan
Tan, Jiaxing
Zhou, Xiaoyuan
Tang, Yi
Qin, Wei
Prognostic Value of Triglyceride to High-Density Lipoprotein Cholesterol Ratio (TG/HDL-C) in IgA Nephropathy Patients
title Prognostic Value of Triglyceride to High-Density Lipoprotein Cholesterol Ratio (TG/HDL-C) in IgA Nephropathy Patients
title_full Prognostic Value of Triglyceride to High-Density Lipoprotein Cholesterol Ratio (TG/HDL-C) in IgA Nephropathy Patients
title_fullStr Prognostic Value of Triglyceride to High-Density Lipoprotein Cholesterol Ratio (TG/HDL-C) in IgA Nephropathy Patients
title_full_unstemmed Prognostic Value of Triglyceride to High-Density Lipoprotein Cholesterol Ratio (TG/HDL-C) in IgA Nephropathy Patients
title_short Prognostic Value of Triglyceride to High-Density Lipoprotein Cholesterol Ratio (TG/HDL-C) in IgA Nephropathy Patients
title_sort prognostic value of triglyceride to high-density lipoprotein cholesterol ratio (tg/hdl-c) in iga nephropathy patients
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251124/
https://www.ncbi.nlm.nih.gov/pubmed/35795149
http://dx.doi.org/10.3389/fendo.2022.877794
work_keys_str_mv AT peigaiqin prognosticvalueoftriglyceridetohighdensitylipoproteincholesterolratiotghdlciniganephropathypatients
AT qinaiya prognosticvalueoftriglyceridetohighdensitylipoproteincholesterolratiotghdlciniganephropathypatients
AT donglingqiu prognosticvalueoftriglyceridetohighdensitylipoproteincholesterolratiotghdlciniganephropathypatients
AT wangsiqing prognosticvalueoftriglyceridetohighdensitylipoproteincholesterolratiotghdlciniganephropathypatients
AT liuxiang prognosticvalueoftriglyceridetohighdensitylipoproteincholesterolratiotghdlciniganephropathypatients
AT yangdandan prognosticvalueoftriglyceridetohighdensitylipoproteincholesterolratiotghdlciniganephropathypatients
AT tanjiaxing prognosticvalueoftriglyceridetohighdensitylipoproteincholesterolratiotghdlciniganephropathypatients
AT zhouxiaoyuan prognosticvalueoftriglyceridetohighdensitylipoproteincholesterolratiotghdlciniganephropathypatients
AT tangyi prognosticvalueoftriglyceridetohighdensitylipoproteincholesterolratiotghdlciniganephropathypatients
AT qinwei prognosticvalueoftriglyceridetohighdensitylipoproteincholesterolratiotghdlciniganephropathypatients